Pakistan’s Supreme Court has ordered the release of two owners of pharmaceutical companies as part of an investigation into deaths caused by the reaction from drugs distributed by the Punjab Institute of Cardiology.

The Federal Investigation Agency (FIA) has also been told to submit an investigative report into the case, following the FIA informing the court that one pharmaceutical company had been manufacturing the drugs without a license.

The order was issued from a three-judge bench headed by Justice Tassaduq Hussain Jillani, who questioned the arrest of the owner of Alpha Pharmaceuticals when no post-mortem reports or findings from the investigation had been presented.

Evidence filed to the court has revealed that most deaths attributed to the drugs were caused by heart attacks, and the suspected drugs have been sent to Belgium, Switzerland and the UK for further testing.

Following the release of two owners on bail, the case has been adjourned until 6 February 2011.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.